AcQblate Force Sensing Ablation System US IDE for Atrial Flutter

Age
18 years - 99 years
Gender
All
participants needed
100
Location
1
AcQblate Force Sensing Ablation System US IDE for Atrial Flutter

Brief description of study

The objective of the clinical study is to demonstrate the AcQBlate Force Sensing System is safe and effective when used to ablate the cavotricuspid isthmus (CTI) for the treatment of typical atrial flutter .

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Flutter
  • Age: 18 years - 99 years
  • Gender: All

Male and Female, Age 18 or older, At least one (1) documented episode of typical atrial flutter within 180 days (6 months)

Updated on 04 Aug 2024. Study ID: 848386
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research